{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-045643","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.401766+00:00","generated_at":"2026-05-21T00:31:18.727728+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Apimeds extends maturity of three promissory notes to May 19, 2026","bullets":["Amended notes from Inscobee ($100k and $150k) and Apimeds Korea ($250k), total $500k principal.","Original maturity dates extended to May 19, 2026; interest remains 5% per annum.","May 2024 and August 2024 notes were due May 19, 2025; March 2025 note was due Dec 31, 2026 or upon NYSE listing.","Amendments executed on May 16, 2025, avoid imminent default on two notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-045643","json":"https://secwatch.observer/filing/0001213900-25-045643.json","markdown":"https://secwatch.observer/filing/0001213900-25-045643.md","text":"https://secwatch.observer/filing/0001213900-25-045643.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/0001213900-25-045643-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701-8k_apimed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T00:31:18.727728+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}